Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine About Us Budget'24
  • Budget'26 Budget'25 Budget'24
    • Home
    • News
    HSBC Upgrade Boosts Tata Motors Share Price: 3 Key Takeaways for Investors

    HSBC Upgrade Boosts Tata Motors Share Price: 3 Key Takeaways for Investors


    Finance Outlook India Team | Monday, 17 March 2025

    Tata Motors stocks experienced a rise early on Monday after HSBC upgraded Tata Motors from Hold rating to Buy. At 9:57 am, the stock price was up by 1.16% and was trading at 663 on the BSE.

    HSBC revised their target price to 840, dropping from an earlier estimate of 930. While the drop is significant, at the revised target price an appreciation of about 29% from the current price would be expected. Improved margins for Tata Motors are being forecasted by the brokerage owing to solid performance by Jaguar Land Rover (JLR) along with improved conditions in Tata Motors' domestic operations.

    JLR's Increasing Profitability

    The outlook on JLR remains positive from HSBC's perspective, especially with the reduction in discounts and warranty costs, which is a testimony of building pricing power and profitability. The brokerage believes re-rating of the stock will happen, should JLR meet annual guidance for the March quarter.

    HSBC also drew attention to how the JLR valuation has declined over the previous quarters. Presently, JLR trades at 1.8x FY26 EV/EBITDA, at the weak end of its long-term trading range.

    Recovering Domestic Operation

    The brokerage noted that Tata Motors' small commercial vehicle (SCV) sales improved, which can be attributed to demand pickup in logistics and transportation. In addition, the impending new model launches can be a boost for Tata's passenger vehicle (PV) segment further strengthening its position in the Indian market.

    Attractive Valuation

    The stock has fallen by 12% in 2025 and is close to its 52-week low. The stock was down 45% from the highs of Rs 1,179 in July 2024. HSBC sees this correction as a great buying opportunity with an improving fundamental outlook.

    The company's board meeting on March 19, 20XX will discuss raising ₹2,000 crores through NCDs.

    Afterwards are some catalysts that improving the JLR margins, recovering domestic business, and product launches. HSBC sees the company poised to turn around. According to analyst estimates, a 25% potential upside is anticipated from the current level.



    Read More:

    India's Retail Inflation Rises to 3.21% IN February

    Juspay and RateGain Partner to Power RG Pay for Travel & Hospitality

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe WRAPUP’25